Indivior Terminates Supply Agreement With Reckitt Benckiser

04:34 AM EDT, 09/16/2026 (MT Newswires) -- Indivior (INDV) and Reckitt Benckiser Healthcare have agreed to accelerate the termination date of their copacker supply agreement for Suboxone and Subutex tablets on Jan. 15, 2027, Indivior said in a regulatory filing on Tuesday. According to the statement, Indivior said it has found a new supplier. The current supply agreement, under which Reckitt Benckiser manufactures the tablets for Indivior, was originally agreed to in 2014, the company said.